Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells

Acute myeloid leukemia (AML) is an hematologic neoplasia characterized by the accumulation of transformed immature myeloid cells in bone marrow. Although the response rate to induction therapy is high, survival rate 5-year after diagnosis is still low, highlighting the necessity of new novel agents....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Cornet-Masana, Josep Maria, Moreno-Martínez, Daniel, Lara-Castillo, María Carmen, Nomdedeu, Meritxell, Etxabe, Amaia, Tesi, Niccolò, Pratcorona, Marta, Esteve, Jordi, Risueño, Ruth M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029623/
https://ncbi.nlm.nih.gov/pubmed/26992240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8096
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars